Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension.

Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension. Abstract Text:

Vivencio Barrios,Carlos Escobar,Vivencio Barrios,Carlos Escobar,Vivencio Barrios,Carlos Escobar,

Although achieving blood pressure (BP) control is critical to improve cardiovascular prognosis in hypertensive patients, many of them fail to attain the targets. Most patients with hypertension need more than one antihypertensive agent to achieve the goals. Combination therapy is required when monotherapy fails to attain BP objectives (< 140/90 mmHg in general hypertensive population; < 130/80 mmHg in high-risk groups) and as a first-line treatment in certain situations, such as markedly elevated BP values, high or very high cardiovascular risk patients or when lower targets are warranted. The advantages of combination therapy are well documented with the potential for increased antihypertensive efficacy as a result of different mechanisms of action, and a lower incidence of adverse effects because of the lower doses used and the possible compensatory responses. The inhibition of the renin-angiotensin system appears to be very beneficial in the treatment of patients with hypertension. Olmesartan medoxomil 20 mg/hydrochlorothiazide 12.5 mg is the latest combination of an angiotensin receptor blocker and a diuretic approved for treatment of hypertension. The aim of this manuscript is to update the published data about the efficacy and safety of this fixed combination.

Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension. Publishing Authors By Initials

V Barrios,C Escobar,V Barrios,C Escobar,V Barrios,C Escobar,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Expert opinion on pharmacotherapy

VOLUME: 9

Page Numbers: 129-36

Journal Abbreviation:

ISSN: 1744-7666

DAY: 13

MONTH: Jan

YEAR: 2008

Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100897346

Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension.

AFFILIATION: Hospital Ramón y Cajal, Department of Cardiology, Ctra. Colmenar km 9.100, 28034 Madrid, Spain +34 91 3368259 ; +34 91 3368665 ; vbarriosa@meditex.es ; vbarrios.hrc@salud.madrid.org.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Expert Opin Pharmacother

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension Related Publications

• "Attitude is a little thing that makes a big difference" Winston Churchill.
• A qualitative analysis of the perception of stigma among latinos receiving antidepressants.
• An acute intracerebral vein thromboses in AIDS with protein C and S deficiency.
• BiosStep-assisted walking in spinal cord-injured patients: an evaluation report.
• Clinical indicators of child development in the capitals of nine Brazilian states: the influence of regional cultural factors.
• Corticosterone and activity: the long arms of the clock talk back.
• Depression management: applying skills in the clinical setting.
• Dialogues on depression management: the primary care and specialist perspectives.
• Distinct heat-shock element arrangements that mediate the heat shock, but not the late-embryogenesis induction of small heat-shock proteins, correlate with promoter activation in root-knot nematode feeding cells.
• Does simple "reassurance" work in patients with medically unexplained physical symptoms?
• Evolution of a Polysulfone Nanofiltration Membrane following Ion Beam Irradiation.
• Five bicyclo[3.3.0]octa-2,6-dienes.
• Heterotopic pregnancy presenting at 18 weeks' gestational age: a case report.
• Incorporation of physiological trend and interaction effects in neonatal severity of illness scores: an experiment using a variant of the Richardson score.
• Instability of copronecrophagous beetle assemblages (coleoptera: scarabaeinae) in a mountainous tropical landscape of Mexico.
• Low relapse with oral antibiotics and two-stage exchange for late arthroplasty infections in 40 patients after 2-9 years.
• Luteinizing hormone-releasing hormone agonist and transferrin functionalizations enhance nanoparticle delivery in a novel bovine ex vivo eye model.
• Lymphomatoid granulomatosis of the skin. A new clinocopathologic entity.
• Maternal and obstetric complications of pregnancy are associated with increasing gestational age at term.
• Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension.
• Pathways to suicidality across ethnic groups in Canadian adults: the possible role of social stress.
• [Antidiabetic drugs prescription patterns among a group of patients in Colombia]
• [Bubonic plague in Peru: a multisectorial approach for control]
• [CONTROLLED SURVEY IN GERIATRICS. II. COMPARATIVE STUDY OF 4 THERAPEUTIC AGENTS.]
• [Changing community attitudes through information campaigns]
• [Health and population in Bogota, Columbia]
• [Not Available.]
• [Role of liver biopsy in the diagnosis and management of chronic hepatitis C]
• [Surgical treatment of the aortic coarctation: three-decade experience.]
• [Technical aspects in skeletonization of the internal thoracic artery using an ultrasonic scalpel.]